Pro Medicus Locks in $37M Renewal at Higher Rates as Imaging Volumes Grow
Pro Medicus secures A$37 million contract renewal with Northwestern Medicine
Pro Medicus (ASX: PME) has secured a five-year, A$37 million contract renewal with Northwestern Medicine for its Visage 7 platform. The renewal, negotiated with improved commercial terms including higher per-transaction fees and increased minimum volume commitments, reflects growing imaging volumes at the Chicago-based academic health system since it standardised on the platform five years ago.
Northwestern Medicine operates over 200 sites across Illinois, including the top-ranked Northwestern Memorial Hospital, and serves as the primary teaching affiliate for Northwestern University Feinberg School of Medicine. The transaction-based structure allows for potential upside beyond the contracted minimum as examination volumes grow.
When big ASX news breaks, our subscribers know first
Strengthened commercial terms signal pricing confidence
The renewed agreement demonstrates two key commercial improvements over the original contract. Pro Medicus has negotiated an increased fee per examination alongside higher minimum volume commitments that reflect the growth in Northwestern Medicine’s imaging activity since adopting Visage 7.
The commercial enhancements include:
- Increased fee per exam
- Higher minimum volume commitments
- Transaction-based structure with upside potential
Chief Executive Officer Dr Sam Hupert noted the higher minimums reflect volume growth since Northwestern Medicine standardised on the platform. The ability to negotiate improved terms on renewal suggests the platform has become more deeply embedded within the health system’s clinical workflows over time.
What is transaction-based healthcare software pricing?
Transaction-based pricing charges customers per medical examination processed through the software platform, rather than a fixed licensing fee. This model differs from traditional enterprise software contracts where organisations pay a set annual fee regardless of usage levels.
Under transaction-based pricing, the software vendor’s revenue grows naturally as the customer’s imaging volumes increase. This creates alignment between vendor success and customer growth, as both parties benefit when examination volumes expand. For health systems experiencing organic patient volume growth or service line expansion, this pricing structure allows software costs to scale proportionally with activity.
A$80 million in renewals contracted in a single month
Dr Hupert revealed that Pro Medicus has contracted nearly A$80 million in renewals over the past month, with the Northwestern Medicine agreement representing A$37 million of that total. The concentrated renewal activity demonstrates the company’s client retention performance within the enterprise healthcare imaging market.
Dr Sam Hupert, Chief Executive Officer
“In the last month we have contracted nearly $80 million in renewals maintaining our track record when it comes to client retention. This underpins our belief that our solution provides unparalleled return on investment from both a financial and clinical perspective.”
The retention of Northwestern Medicine, a prestigious academic medical centre, validates the competitive positioning of Visage 7 within large health systems that demand both clinical functionality and financial value.
The next major ASX story will hit our subscribers first
What this means for Pro Medicus shareholders
The Northwestern Medicine renewal carries several implications for Pro Medicus shareholders:
- Revenue durability through multi-year renewals — The five-year contract term provides visibility into future cash flows from an established customer base
- Pricing power demonstrated through improved commercial terms — The ability to negotiate higher fees and minimums on renewal indicates customers are deriving increasing value from the platform
- Built-in growth from transaction-based model tied to customer volumes — As Northwestern Medicine’s imaging volumes expand organically, Pro Medicus benefits from higher revenue without requiring additional contract wins
The A$80 million in recent renewals suggests Pro Medicus has successfully transitioned early customers from initial deployments into long-term commercial relationships. For a software company operating in the enterprise healthcare market, where switching costs are high and implementation timelines are measured in years, retention at improved pricing terms indicates a defensible competitive moat.
The transaction-based revenue model provides organic growth as existing customers process more examinations, reducing reliance on new customer acquisition to drive top-line expansion. This dynamic becomes particularly valuable as Pro Medicus’s installed base matures and renewal activity accelerates.
Want the Next Healthcare Software Winner in Your Inbox?
Join 20,000+ investors receiving FREE breaking ASX healthcare news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to get market-moving announcements the moment they break.